Global Biotech Stocks

MacroGenics

Market Cap: US$104.3m

A clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States.

IO Biotech

Market Cap: US$104.1m

A clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform.

Orexo

Market Cap: SEK 976.6m

A specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally.

Nautilus Biotechnology

Market Cap: US$103.8m

A development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome.

JiangSu WuZhong Pharmaceutical Development

Market Cap: CN¥738.2m

JiangSu WuZhong Pharmaceutical Development Co., Ltd.

Vistagen Therapeutics

Market Cap: US$103.4m

A clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders.

Alto Neuroscience

Market Cap: US$102.9m

Operates as a clinical-stage biopharmaceutical company in the United States.

Vistin Pharma

Market Cap: NOK 1.0b

Through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide.

Shield Therapeutics

Market Cap: UK£76.4m

A commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs.

Pak Fah Yeow International

Market Cap: HK$772.9m

An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.

Kangstem Biotech

Market Cap: ₩140.1b

A biopharmaceutical company, develops stem cell therapeutic products for rare and incurable diseases.

High Tech Pharm

Market Cap: ₩139.4b

Researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide.

Burning Rock Biotech

Market Cap: US$98.1m

Develops and sells cancer therapy selection tests in the People's Republic of China and the United States.

Wanbury

Market Cap: ₹8.6b

Manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally.

Atara Biotherapeutics

Market Cap: US$97.1m

Engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and the United Kingdom.

Bharat Parenterals

Market Cap: ₹8.5b

Engages in the research, development, manufacturing, marketing, sourcing, and distribution of pharmaceutical products in India and internationally.

ALX Oncology Holdings

Market Cap: US$95.9m

A clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States.

BioSyent

Market Cap: CA$133.0m

Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.

Adagene

Market Cap: US$95.2m

A clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People’s Republic of China.

Unité de Fabrication des Médicaments

Market Cap: د.ت276.2m

Unité de Fabrication des Médicaments S.A.

HeXun Biosciences

Market Cap: NT$2.9b

Engages in the research and development of stem cell and treatments in Taiwan.

Kopran

Market Cap: ₹8.4b

An integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally.

Jeil Pharma Holdings

Market Cap: ₩133.4b

Manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea.

Gwo Xi Stem Cell Applied Technology

Market Cap: NT$2.9b

Develops stem cell medicines for patients with unmet medical needs.

Anuh Pharma

Market Cap: ₹8.3b

Engages in the manufacture and sale of bulk drugs and chemicals in India.

Werewolf Therapeutics

Market Cap: US$92.4m

A biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and other immune-mediated conditions.

DK Life Science

Market Cap: ₩129.9b

A pharmaceutical company, develops and sells diagnostic medicines and medical devices in South Korea, the European Union, Japan, and internationally.

CG Invites

Market Cap: ₩128.6b

A biopharma company, engages in the discovery and development of structural chemoproteiomics-based drugs in Korea.

Acumen Pharmaceuticals

Market Cap: US$89.6m

A clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer’s disease.

GlycoNex Incorporation

Market Cap: NT$2.7b

Engages in the development of cancer drugs using glycosphingolipid antigen and human monoclonal antibody technologies in Taiwan.

Turk Ilac Ve Serum Sanayi Anonim Sirketi

Market Cap: ₺3.7b

Produces and sells pharmaceutical products in Turkey.

Kalaris Therapeutics

Market Cap: US$89.2m

A clinical-stage ophthalmology biotech company, engages in developing therapies for the treatment of neovascular retinal diseases.

Vita Life Sciences

Market Cap: AU$136.3m

A healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China.

MPH Health Care

Market Cap: €76.0m

An investment company, engages in the healthcare business in Germany.

Coya Therapeutics

Market Cap: US$88.8m

A clinical-stage biotechnology company, develops proprietary therapies to enhance the function of regulatory T cells (Tregs).

Pliant Therapeutics

Market Cap: US$88.4m

A biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases.